- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Maraviroc – November 2012
Maraviroc, tablets, 150 mg and 300 mg, Celsentri®
Last updated
8 November 2023